These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 455333)

  • 1. Preliminary phase I study of 4'-epi-adriamycin.
    Bonfante V; Bonadonna G; Villani F; Di Fronzo G; Martini A; Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):915-8. PubMed ID: 455333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
    Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A phase II study of epirubicin in advanced lung cancer].
    Furuse K; Fukuoka M; Yamamoto M; Kawahara M; Tsuruta M; Kodama N; Arai R; Hayashi S; Kiyota M; Kubota K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2835-40. PubMed ID: 3019252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin].
    Toda K; Asaishi K; Okazaki M; Okazaki Y; Okazaki A; Sato H; Mikami T; Watanabe Y; Hayasaka H; Narimatsu E
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3011-4. PubMed ID: 2782905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oriented phase II trial of THP-adriamycin in breast carcinoma.
    Mathé G; Umezawa H; Oka S; Misset JL; Brienza S; de Vassal F; Musset M; Ribaud P; Tapiero H
    Biomed Pharmacother; 1986; 40(10):376-9. PubMed ID: 3580506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)].
    Majima H
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):805-10. PubMed ID: 6882000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
    Nakada H; Ogawa M; Miyamoto H; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
    Kimura K; Wakui A; Saito T; Tominaga T; Niitani H; Fujimoto T; Masaoka T; Toki H; Tamura K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clinical trial with quelamycin.
    Cortés-Funes H; Gosálvez M; Moyano A; Mañas A; Mendiola C
    Cancer Treat Rep; 1979 May; 63(5):903-8. PubMed ID: 455331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog.
    Blum RH; Garnick MB; Israel M; Canellos GP; Henderson IC; Frei E
    Cancer Treat Rep; 1979 May; 63(5):919-23. PubMed ID: 455334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
    Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
    Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary phase II study of adriamycin (ADM) in patients with non-small cell lung cancer (NSCLC).
    Fujita J; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Sakurai M; Futami H; Ishihara J; Takahashi H
    Jpn J Clin Oncol; 1985 Jun; 15(2):365-8. PubMed ID: 4021119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II study of epirubicin in malignant lymphoma].
    Masaoka T; Shibata H; Sampi K; Hirota Y; Yoshida Y; Chiba Y; Shirakawa S; Kobayashi T; Toki H; Tamura K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2606-11. PubMed ID: 3461747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
    Miller AA; Schmidt CG
    Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
    Jones WG; Mattsson W
    Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of acute cardiotoxicity of anti-cancer agents-- analysis using Holter ECG monitoring].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1893-900. PubMed ID: 3164181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adriamycin in chemotherapy of solid tumors].
    Lovisetto P; Pochettino G; Biarese V
    Minerva Med; 1975 May; 66(35):1653-63. PubMed ID: 1128811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A randomized phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin and adriamycin in combination with vincristine and ACNU in small cell lung cancer--THP-ADM, VCR, ACNU vs ADM, VCR, ACNU].
    Hino M; Kobayashi K; Kurane S; Nukariya N; Yamano Y; Hasegawa K; Tsuboi E; Niitani H
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3143-8. PubMed ID: 2551250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
    Michaelson R; Kemeny N; Young C
    Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.